A convenient procedure for the conversion of N-Boc protected pyrrolidinone derivatives into their corresponding enecarbamates

Article abstract of DOI:10.1080/00397919708004150

When N-Boc protected pyrrolidinone derivatives are treated by Dibal-H and then by quinolinium camphorsulfonate, they are converted into their corresponding enecarbamate.

Full text of DOI:10.1080/00397919708004150

This article was downloaded by: [Fordham University]
On: 12 January 2013, At: 08:43
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954
Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH,
UK
Synthetic Communications: An
International Journal for Rapid
Communication of Synthetic
Organic Chemistry
Publication details, including instructions for
authors and subscription information:
http://www.tandfonline.com/loi/lsyc20
A Convenient Procedure
for the Conversion Of N-
Boc Protected Pyrrolidinone
Derivatives Into Their
Corresponding Enecarbamates
J. Cossy a , M. Cases a & D. Gomez Pardo a
a Laboratoire de Chimie Organique Associé au CNRS,
ESPCI, 10 Rue Vauquelin, 75231, Paris, Cedex 05
Version of record first published: 22 Aug 2006.
To cite this article: J. Cossy , M. Cases & D. Gomez Pardo (1997): A Convenient
Procedure for the Conversion Of N-Boc Protected Pyrrolidinone Derivatives Into Their
Corresponding Enecarbamates, Synthetic Communications: An International Journal
for Rapid Communication of Synthetic Organic Chemistry, 27:16, 2769-2776
To link to this article: http://dx.doi.org/10.1080/00397919708004150
PLEASE SCROLL DOWN FOR ARTICLE
Full terms and conditions of use: http://www.tandfonline.com/page/terms-
and-conditions
This article may be used for research, teaching, and private study purposes.
Any substantial or systematic reproduction, redistribution, reselling, loan,
sub-licensing, systematic supply, or distribution in any form to anyone is
expressly forbidden.

The publisher does not give any warranty express or implied or make any
representation that the contents will be complete or accurate or up to
date. The accuracy of any instructions, formulae, and drug doses should be
independently verified with primary sources. The publisher shall not be liable
for any loss, actions, claims, proceedings, demand, or costs or damages
whatsoever or howsoever caused arising directly or indirectly in connection
with or arising out of the use of this material.